Disease screening, including prostate-specific antigen (PSA) test and digital rectal exam (DRE), and pathological characterization of biopsy tissues substantially contribute to the diagnosis and early risk stratification for patients with prostate cancer. The gene discussed is KLK3; the disease is prostate cancer.